Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs in Chronic Cervical SCI
NCT02574572Phase 1Unknown
- Sponsor
- Hospital São Rafael
- Start
- Sep 2017
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous mesenchymal stem cells in spinal cord injury (SCI), sponsored by Hospital São Rafael. Primary endpoint: Number of participants with treatment-related adverse events as assessed by magnetic resonance imaging at 12 months. Status: unknown.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02574572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574572.